Trabeculectomy with mitomycin C for glaucoma secondary to emulsified silicone oil after pars plana vitrectomy: three-years follow up

Background/Aim. Different surgical interventions have been proposed, including trabeculectomy associated with antiproliferative agents because silicone oil (SO) removal cannot necessarily provide intraocular pressure (IOP) control. The aim of the study was to determine efficacy mitomycin C (MMC) for lowering IOP in patients open-angle glaucoma (OAG) secondary emulsified SO after pars plana vitrectomy. Methods. A single-center, prospective conducted, from December 2014 2019, on 56 consecutive an uncontrolled elevation who were subjected MMC that period. primary end-point at three-year follow-up visit. Complete success defined as ranging 7 mmHg 18 without medication. Qualified a s I OP ? 2 1 m mHg one or two topical medications. Results. Fifty-six mean age 5 3.6 [standard deviation (SD)15.5] years had baseline 42.3 (39.3 45.3) mmHg, which reduced 18.6 (17.9 19.3) three surgery (p < 0.0001). Seventeen (30.4%) eyes classified complete success, 21 (37,5%) qualified and (32.1%) failure. In all successfully treated patients, number antiglaucoma medications significantly 2.85 (SD 0.77) 1.63 0.62), p 0.0001. Conclusion. Trabeculectomy may be option OAG vitrectomy, not controlled maximum